180 related articles for article (PubMed ID: 29621378)
1. Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial.
Fallon MT; Wilcock A; Kelly CA; Paul J; Lewsley LA; Norrie J; Laird BJA
JAMA Oncol; 2018 Jun; 4(6):870-872. PubMed ID: 29621378
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: a placebo-controlled trial.
Vranken JH; Dijkgraaf MG; Kruis MR; van Dasselaar NT; van der Vegt MH
Pain; 2005 Nov; 118(1-2):224-31. PubMed ID: 16202531
[TBL] [Abstract][Full Text] [Related]
3. Ketamine mouthwash versus placebo in the treatment of severe oral mucositis pain in children with cancer: A randomized double-blind placebo-controlled trial.
Prakash S; Meena JP; Gupta AK; Bakhshi S; Velpandian T; Pandey RM; Seth R
Pediatr Blood Cancer; 2020 Sep; 67(9):e28573. PubMed ID: 32648983
[TBL] [Abstract][Full Text] [Related]
4. Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial.
Pickering G; Pereira B; Morel V; Corriger A; Giron F; Marcaillou F; Bidar-Beauvallot A; Chandeze E; Lambert C; Bernard L; Delage N
Anesthesiology; 2020 Jul; 133(1):154-164. PubMed ID: 32384291
[TBL] [Abstract][Full Text] [Related]
5. Ketamine for cancer pain: what is the evidence?
Jonkman K; van de Donk T; Dahan A
Curr Opin Support Palliat Care; 2017 Jun; 11(2):88-92. PubMed ID: 28306568
[TBL] [Abstract][Full Text] [Related]
6. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
7. Ketamine as an adjuvant to opioids for cancer pain.
Bell RF; Eccleston C; Kalso EA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003351. PubMed ID: 28657160
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.
Lynch ME; Cesar-Rittenberg P; Hohmann AG
J Pain Symptom Manage; 2014 Jan; 47(1):166-73. PubMed ID: 23742737
[TBL] [Abstract][Full Text] [Related]
9. Ketamine: When Delirium and Desperation Call for a Hero.
Moazam C; Hirst J; Mesarwi P; Atayee RS
J Pain Palliat Care Pharmacother; 2019; 33(3-4):120-124. PubMed ID: 31689170
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a randomized double-blind clinical trial in breast cancer: dextromethorphan in chemotherapy-induced peripheral neuropathy.
Martin E; Morel V; Joly D; Villatte C; Delage N; Dubray C; Pereira B; Pickering G
Contemp Clin Trials; 2015 Mar; 41():146-51. PubMed ID: 25636304
[TBL] [Abstract][Full Text] [Related]
11. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
[TBL] [Abstract][Full Text] [Related]
12. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
[TBL] [Abstract][Full Text] [Related]
13. Ketamine for analgesia.
Daley M; Roberts JC; Washington S
Br J Hosp Med (Lond); 2012 Jun; 73(6):358. PubMed ID: 22875332
[No Abstract] [Full Text] [Related]
14. Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients.
Pickering G; Pereira B; Morel V; Tiberghien F; Martin E; Marcaillou F; Picard P; Delage N; de Montgazon G; Sorel M; Roux D; Dubray C
Contemp Clin Trials; 2014 Jul; 38(2):314-20. PubMed ID: 24948402
[TBL] [Abstract][Full Text] [Related]
15. Oral ketamine for neuropathic cancer pain.
Calsina-Berna A; Alvaro Pardo M; Cucurull Salamero M; Bleda-Perez M; Julià-Torras J
BMJ Support Palliat Care; 2024 Jan; 13(e3):e968-e970. PubMed ID: 37225396
[TBL] [Abstract][Full Text] [Related]
16. Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study.
Uzaraga I; Gerbis B; Holwerda E; Gillis D; Wai E
Support Care Cancer; 2012 Jul; 20(7):1515-24. PubMed ID: 21847539
[TBL] [Abstract][Full Text] [Related]
17. Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial.
Delage N; Morel V; Picard P; Marcaillou F; Pereira B; Pickering G
Trials; 2017 Nov; 18(1):517. PubMed ID: 29100524
[TBL] [Abstract][Full Text] [Related]
18. Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial.
Goldlust SA; Kavoosi M; Nezzer J; Kavoosi M; Korz W; Deck K
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33805908
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.
Hardy J; Quinn S; Fazekas B; Plummer J; Eckermann S; Agar M; Spruyt O; Rowett D; Currow DC
J Clin Oncol; 2012 Oct; 30(29):3611-7. PubMed ID: 22965960
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy.
Dou Z; Jiang Z; Zhong J
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e57-e64. PubMed ID: 25530068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
